Laurel Wealth Advisors (California)’s Galectin Therapeutics GALT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-16,600
| Closed | -$85K | – | 399 |
|
|
2019
Q1 | $85K | Hold |
16,600
| – | – | 0.02% | 383 |
|
|
2018
Q4 | $56K | Hold |
16,600
| – | – | 0.02% | 337 |
|
|
2018
Q3 | $99K | Hold |
16,600
| – | – | 0.02% | 385 |
|
|
2018
Q2 | $105K | Sell |
16,600
-4,800
| -22% | -$30.4K | 0.03% | 376 |
|
|
2018
Q1 | $101K | Buy |
+21,400
| New | +$101K | 0.03% | 347 |
|
|
2017
Q4 | – | Sell |
-16,000
| Closed | -$34K | – | 342 |
|
|
2017
Q3 | $34K | Hold |
16,000
| – | – | 0.01% | 310 |
|
|
2017
Q2 | $39K | Buy |
16,000
+1,000
| +7% | +$2.44K | 0.01% | 293 |
|
|
2017
Q1 | $34K | Buy |
15,000
+5,000
| +50% | +$11.3K | 0.01% | 271 |
|
|
2016
Q4 | $9K | Buy |
+10,000
| New | +$9K | ﹤0.01% | 252 |
|